玩股撇步(動畫小學堂)  

  • 大部份公司都有淡旺季, 所以通常是看年增率
  • 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
  • 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
  • 留意短期平均營收向上或向下穿越長期平均營收
  • 觀察累計營收年增率的累計增加或虧損收斂
每月營收 (營收搶先看自結損益)
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/22.86-31.92-34.997.06-37.1510.41N/A-
2024/14.225.29-38.544.2-38.5411.11N/A-
2023/123.35-5.6-30.6148.07-50.0610.78N/A本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/113.55-8.45-14.0744.72-51.0911.09N/A本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/103.886.17-57.5941.16-52.8410.52N/A本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/93.6522.38-42.5337.28-52.2910.011.3本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/82.99-11.28-45.9133.63-53.1510.271.26本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/73.37-14.21-72.130.64-53.7511.951.09本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/63.92-15.79-66.7727.28-49.6711.921.06本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/54.6639.59-61.3923.36-44.9112.121.04本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/43.34-19.02-73.0818.7-38.3511.861.07本年係因新冠肺炎抗原快篩檢驗試劑銷售減少
2023/34.12-6.31-27.2415.36-14.3315.360.96-
2023/24.4-35.64-8.6911.24-8.3716.070.91-
2023/16.8441.47-8.166.84-8.1615.80.93-
2022/124.8316.898.6396.2748.2518.120.9-
2022/114.13-54.82-20.8291.4451.1719.640.83本年係因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/109.1543.9127.287.357.9721.030.77本年係因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/96.3615.18-4.7678.1552.5323.950.73本年係因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/85.52-54.24-24.5771.7961.1129.390.59因新冠肺炎抗原快篩檢驗試劑銷售減少
2022/712.072.1972.4566.2777.9635.940.49因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/611.81-2.1630.8354.2179.2336.280.57因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/512.07-2.68171.0642.499.8130.140.69因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/412.4118.89275.6930.3380.8922.890.91因新冠肺炎抗原快篩檢驗試劑銷售增加
2022/35.6717.5731.0417.9333.1417.930.86-
2022/24.82-35.2725.3812.2634.1316.710.92-
2022/17.4467.3540.487.4440.4817.110.9-
2021/124.45-14.79-21.2664.9310.1513.71.05-
2021/115.2229.6235.7360.4813.4815.930.91-
2021/104.03-39.68-9.5755.2611.7518.020.8-
2021/96.68-8.7622.7551.2413.8620.990.7-
2021/87.324.6169.144.5612.6423.340.63因新冠肺炎抗原快篩檢驗試劑銷售增加
2021/77.0-22.4734.3237.245.720.470.72-
2021/69.02102.6893.2230.240.7416.780.88因新冠肺炎抗原快篩檢驗試劑銷售增加
2021/54.4534.88-30.0321.22-16.2912.081.22-
2021/43.3-23.65-48.016.77-11.6911.471.29-
2021/34.3212.5-17.1913.476.5413.471.11-
2021/23.84-27.47-6.829.1423.2414.791.01-
2021/15.3-6.260.915.360.9114.791.01因新冠肺炎額溫槍銷售增加
2020/125.6546.8823.8858.9542.2913.951.09-
2020/113.85-13.643.8353.344.5713.741.11-
2020/104.45-18.1135.5549.4549.1214.221.07-
2020/95.4425.67102.9745.050.6114.981.01因武漢肺炎額溫銷售增加
2020/84.33-16.8921.0339.5645.4514.211.07-
2020/75.2111.5238.6635.2349.1516.240.93-
2020/64.67-26.640.0430.0251.1417.380.84因武漢肺炎額溫槍銷售增加
2020/56.360.2383.8325.3553.3817.930.81因武漢肺炎額溫槍銷售增加
2020/46.3521.59105.1318.9945.3115.690.93因武漢肺炎額溫槍銷售増加
2020/35.2226.5847.6412.6426.7412.640.86-
2020/24.1225.2455.687.4215.2611.980.91因武漢肺炎額溫槍銷售增加
2020/13.29-27.78-13.023.29-13.0211.560.94-
2019/124.5623.111.6141.42-4.6911.550.82-
2019/113.712.73-10.5136.86-6.399.670.98-
2019/103.2922.6-16.8233.16-5.99.540.99-
2019/92.68-25.05-37.7429.87-4.5210.011.03-
2019/83.58-4.79-1.8427.190.7610.670.96-
2019/73.7612.63-14.4123.621.1710.550.97-
2019/63.33-3.65-3.5219.864.789.891.13-
2019/53.4611.85-7.0416.536.6310.091.1-
2019/43.09-12.481.1313.0710.960.0N/A-
2019/33.5433.477.29.9714.410.0N/A-
股價
長短期營收
營收年增率
存貨銷售比
由營收觀察是否有淡旺季的情況
年/月營收年/月營收年/月營收年/月營收年/月營收
2024/14.22023/16.842022/17.442021/15.32020/13.29
2024/22.862023/24.42022/24.822021/23.842020/24.12
N/AN/A2023/34.122022/35.672021/34.322020/35.22
N/AN/A2023/43.342022/412.42021/43.32020/46.35
N/AN/A2023/54.662022/512.072021/54.452020/56.36
N/AN/A2023/63.922022/611.812021/69.022020/64.67
N/AN/A2023/73.372022/712.072021/77.02020/75.21
N/AN/A2023/82.992022/85.522021/87.322020/84.33
N/AN/A2023/93.652022/96.362021/96.682020/95.44
N/AN/A2023/103.882022/109.152021/104.032020/104.45
N/AN/A2023/113.552022/114.132021/115.222020/113.85
N/AN/A2023/123.352022/124.832021/124.452020/125.65
  • 每季的合約負債通常會反應在未來半年到一年後的營收
合約負債-近20季, 最新合約負債佔股本: 13.21%
合約負債 QoQ YoY
23Q3 (20)1.261.61-32.26
23Q2 (19)1.24-3.12-63.95
23Q1 (18)1.28-21.95-17.42
22Q4 (17)1.64-11.83-17.17
22Q3 (16)1.86-45.93-13.89
22Q2 (15)3.44121.9496.57
22Q1 (14)1.55-21.72-1.9
21Q4 (13)1.98-8.334.76
21Q3 (12)2.1623.4353.19
21Q2 (11)1.7510.7680.41
21Q1 (10)1.58-16.41.94
20Q4 (9)1.8934.04195.31
20Q3 (8)1.4145.3690.54
20Q2 (7)0.97-37.4267.24
20Q1 (6)1.55142.1980.23
19Q4 (5)0.64-13.51-33.33
19Q3 (4)0.7427.590.0
19Q2 (3)0.58-32.560.0
19Q1 (2)0.86-10.420.0
18Q4 (1)0.960.00.0

每月營收相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。